The impact of early acute rejection on kidney graft survival after repeat kidney transplantation
Open Access
- 21 September 2021
- journal article
- Published by IPO Association of Transplantologists in Transplantologiya
- Vol. 13 (3), 260-271
- https://doi.org/10.23873/2074-0506-2021-13-3-260-271
Abstract
Introduction. Despite the improvements in immunosuppressive therapy, the growing number of repeat kidney transplantations and associated risks of acute rejection make it relevant to assess the impact of early acute rejection on a long-term kidney graft survival.Objective. The aim of the study was to evaluate the rate, the clinical aspects of early acute rejection after repeat kidney transplantation and the outcomes of its treatment, to perform the assessment of the impact of rejection episodes on a long-term kidney graft survival.Material and methods. We carried out the retrospective analysis of kidney graft survival after 121 repeat kidney transplantations performed in N.V. Sklifosovsky Research Institute for Emergency Medicine in the period from 2007 to 2018. Group I included 96 recipients after kidney transplantation without acute rejection in postoperative period. Group II consisted of 25 patients with early acute rejection after kidney transplantation. We performed the assessment of the impact of early acute rejection on the kidney graft survival in comparison with recipients with uncomplicated postoperative period. Statistical processing was carried out by nonparametric methods. Survival was assessed using the Kaplan–Meier curves.Results. 1-year and 3-year kidney graft survival rates amounted to 90.3% (95%, confidence interval 85–95) and 85.4% (95%, CI 79–91), respectively, in recipients of Group I; and 72% (95%, CI 58–86) and 60% (95%, CI 46–76) in patients of Group II. Significant differences in 1-year and 3-year kidney graft survival between patients of Group I and II have been noticed (P=0.0022 and P=0.0065, respectively).Conclusions. Patients with early acute rejection after kidney transplantation had poorer kidney graft survival in comparison with patients without rejection episodes in postoperative period.Keywords
This publication has 13 references indexed in Scilit:
- A 2018 Reference Guide to the Banff Classification of Renal Allograft PathologyTransplantation, 2018
- Treatment of Acute Antibody-Mediated RejectionExpanded Hemodialysis: Innovative Clinical Approach in Dialysis, 2017
- Donor-Specific Antibodies in Kidney Transplant RecipientsClinical Journal of the American Society of Nephrology, 2017
- Antibody-Mediated Acute Vascular Rejection of Kidney Allografts: Fifteen-Year Follow-upTransplantation Proceedings, 2016
- Acute antibody-mediated rejection in kidney transplant recipientsTransplantation Reviews, 2016
- Treatment of Antibody‐Mediated Rejection After Kidney Transplantation – 10 Years’ Experience With Apheresis at a Single CenterTherapeutic Apheresis and Dialysis, 2016
- Clinicopathologic Features and Treatment Response of Early Acute Antibody-Mediated Rejection in Thai Kidney Transplant Recipients: A Single-Center ExperienceTransplantation Proceedings, 2014
- Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel ApproachesAmerican Journal of Transplantation, 2014
- Antibody-mediated rejection, T cell–mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsiesKidney International, 2014
- The Banff classification revisitedKidney International, 2013